|
| Perspective From Industry Leaders |
|
|
| Pharma Facing Growing Risks From Geopolitics, Industry Leaders Warn | Pharma Happy To Be Custodian For Innovative Science From Cash-Strapped Biotechs |
|
Industry leaders and experts at the Financial Times Pharma and Biotech Summit said the US relationship... |
C-suite leaders from Lilly, Roche and J&J spoke at a Citeline-sponsored panel at Swiss Biotech Day in Basel... |
| Licensing & Collaboration Agreements |
|
|
| Vividion’s Breakthrough Science Is Fueling Bayer’s Pipeline | Deal Watch: Six Small Biopharma Mergers Reflect Recent Trend |
|
Leveraging the biotech entrepreneurial spirit and global pharma resources is a win-win situation in the race... |
M&A edition: Mergers by Century/Clade, Eliem/Tenet, Kintara/TuHURA, Aditxt/Appili, Onconova/Traws... |
| Next Gen R&D |
|
|
| Hibernating Squirrels And Exercise In A Pill: The Next Wave of Cardiometabolic Therapies | Could Eledon’s Anti-CD40L Change Transplant Medicine? |
|
Early-stage companies pioneering new modalities discussed the future of cardiometabolic therapy and... |
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression... |
| Clinical Trials |
|
|
| EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials | ICER Debuts Clinical Trial Diversity Assessment Framework |
|
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct... |
The new tool provides a way of quantifying the degree of diversity by race/ethnicity, sex and age in... |
|
|
|
Citeline Contact Poornachandra Tejasvi .K, 
|
IPA Contact Name: Hari Pranav K |